Hydroxyurea Capsules 200 mg, 300 mg, 400 mg and Perflutren Protein Type A
Determining the interaction of Hydroxyurea Capsules 200 mg, 300 mg, 400 mg and Perflutren Protein Type A and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: hydroxyurea
Brand name: Droxia, Hydrea, Mylocel, Siklos
Synonyms: Hydroxyurea
Generic Name: perflutren
Brand name: Definity, Optison
Synonyms: Perflutren, Perflutren Lipid Microspheres
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Hydroxyurea Capsules 200 mg, 300 mg, 400 mg-Perflutren protein type a microsphere Intravenous
- Hydroxyurea Capsules 200 mg, 300 mg, 400 mg-Perforomist
- Hydroxyurea Capsules 200 mg, 300 mg, 400 mg-Perforomist, Symbicort
- Hydroxyurea Capsules 200 mg, 300 mg, 400 mg-Pergolide
- Hydroxyurea Capsules 200 mg, 300 mg, 400 mg-Pergonal
- Hydroxyurea Capsules 200 mg, 300 mg, 400 mg-Peri-Colace
- Perflutren Protein Type A-Hydroxyurea Capsules 500 mg
- Perflutren Protein Type A-Hydroxyurea Tablets
- Perflutren Protein Type A-Hydroxyzine
- Perflutren Protein Type A-Hydroxyzine Capsules
- Perflutren Protein Type A-Hydroxyzine Capsules and Tablets
- Perflutren Protein Type A-Hydroxyzine Hydrochloride